Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease

The Effect of Topical Pranoprofen 0.1% on the Clinical Evaluation and Conjunctival HLA-DR Expression in Dry Eyes. A Single-Site, Prospective Randomized, Clinical study.

Additive Effect of Preservative-free Sodium Hyaluronate 0.1% in Treatment of Dry Eye Syndrome with Diquafosol 3% Eye Drops. A Randomize group, case-control study.

Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study

Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops. A Prospective, Randomized, Controlled study

Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease. A Randomize, Multicenter, phase III Clinical trial.